Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
STP-938 by Step Pharma for Marginal Zone B-cell Lymphoma: Likelihood of Approval
STP-938 is under clinical development by Step Pharma and currently in Phase II for Marginal Zone B-cell Lymphoma. According to...
STP-938 by Step Pharma for Solid Tumor: Likelihood of Approval
STP-938 is under clinical development by Step Pharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
STP-938 by Step Pharma for Marginal Zone B-cell Lymphoma: Likelihood of Approval
STP-938 is under clinical development by Step Pharma and currently in Phase II for Marginal Zone B-cell Lymphoma. According to...